These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 20047477)

  • 1. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
    Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone and azithromycin for the treatment of babesiosis.
    Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A
    N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone and azithromycin treatment for babesiosis in an infant.
    Raju M; Salazar JC; Leopold H; Krause PJ
    Pediatr Infect Dis J; 2007 Feb; 26(2):181-3. PubMed ID: 17259886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent and relapsing babesiosis in immunocompromised patients.
    Krause PJ; Gewurz BE; Hill D; Marty FM; Vannier E; Foppa IM; Furman RR; Neuhaus E; Skowron G; Gupta S; McCalla C; Pesanti EL; Young M; Heiman D; Hsue G; Gelfand JA; Wormser GP; Dickason J; Bia FJ; Hartman B; Telford SR; Christianson D; Dardick K; Coleman M; Girotto JE; Spielman A
    Clin Infect Dis; 2008 Feb; 46(3):370-6. PubMed ID: 18181735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
    Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
    J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
    Vyas JM; Telford SR; Robbins GK
    Clin Infect Dis; 2007 Dec; 45(12):1588-90. PubMed ID: 18190320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia.
    Simon MS; Westblade LF; Dziedziech A; Visone JE; Furman RR; Jenkins SG; Schuetz AN; Kirkman LA
    Clin Infect Dis; 2017 Oct; 65(7):1222-1225. PubMed ID: 28541469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M; Lederman J; Tanowitz HB; Rosenbaum GS; Weiss LM
    Am J Trop Med Hyg; 1996 Aug; 55(2):219-22. PubMed ID: 8780464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
    Jefferies R; Ryan UM; Jardine J; Robertson ID; Irwin PJ
    Exp Parasitol; 2007 Oct; 117(2):115-23. PubMed ID: 17543304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin.
    Di Cicco MF; Downey ME; Beeler E; Marr H; Cyrog P; Kidd L; Diniz PP; Cohn LA; Birkenheuer AJ
    Vet Parasitol; 2012 Jun; 187(1-2):23-7. PubMed ID: 22305297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy against babesiosis.
    Vial HJ; Gorenflot A
    Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
    Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
    J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.
    Wudhikarn K; Perry EH; Kemperman M; Jensen KA; Kline SE
    Am J Med; 2011 Sep; 124(9):800-5. PubMed ID: 21683324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital babesiosis in a four-week-old female infant.
    Aderinboye O; Syed SS
    Pediatr Infect Dis J; 2010 Feb; 29(2):188. PubMed ID: 20118748
    [No Abstract]   [Full Text] [Related]  

  • 16. Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
    Arsuaga M; González LM; Padial ES; Dinkessa AW; Sevilla E; Trigo E; Puente S; Gray J; Montero E
    Emerg Infect Dis; 2018 Aug; 24(8):1588-1589. PubMed ID: 30016247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Pudney M
    J Parasitol; 1999 Aug; 85(4):723-8. PubMed ID: 10461956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated babesiosis in a 7-month-old infant after bidirectional Glenn procedure.
    Nicholson GT; Walsh CA; Madan RP
    Congenit Heart Dis; 2010; 5(6):607-13. PubMed ID: 21106022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin.
    Sakuma M; Setoguchi A; Endo Y
    J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone.
    Kletsova EA; Spitzer ED; Fries BC; Marcos LA
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):26. PubMed ID: 28399851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.